[1]
Kaczorowska-Kossowska, I. 2022. Admissibility of Using the Medicinal Products that Have Not Been Authorised in National Procedure. LAW & SOCIAL BONDS. 2 (40) (Jul. 2022), 30–44. DOI:https://doi.org/10.36128/priw.vi40.256.